Literature DB >> 3141076

Benzamides can stimulate as well as inhibit the activity of nuclear ADP-ribosyltransferase.

J Jones1, B N Patel, C J Skidmore.   

Abstract

Benzamides are potent inhibitors of nuclear ADP-ribosyltransferase and have been extensively used to demonstrate the involvement of ADP-ribosylation in cellular function. When permeabilized L1210 cells are treated with 50 microM 3-acetylamidobenzamide (3-aab) the enzyme is inhibited. However, when 50 nM 3-aab is used a two-fold stimulation of enzyme activity is produced. This anomalous stimulation is obtained with benzamides and nicotinamides and is correlated with their activity as inhibitors. Strikingly the steady-state level of poly(ADP-ribose) in intact cells is increased by these low levels of inhibitors. The mechanisms of this effect and its consequences for the experimental use of benzamides are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141076     DOI: 10.1093/carcin/9.11.2023

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

Review 1.  Inhibitors and activators of ADP-ribosylation reactions.

Authors:  M Banasik; K Ueda
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

2.  Purification and characterization of NAD+:ADP-ribosyltransferase (polymerizing) from Dictyostelium discoideum.

Authors:  B Kofler; E Wallraff; H Herzog; R Schneider; B Auer; M Schweiger
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

3.  Effects of 3-aminobenzamide on induction of multiorgan carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine in hamsters.

Authors:  T Tsujiuchi; M Tsutsumi; A Denda; T Amanuma; S Kondoh; K Kamino; Y Konishi
Journal:  Jpn J Cancer Res       Date:  1991-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.